News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
877,149 Results
Type
Article (88419)
Company Profile (813)
Press Release (787887)
Multimedia
Podcasts (220)
Webinars (34)
Section
Business (233434)
Career Advice (4155)
Deals (39924)
Drug Delivery (168)
Drug Development (91557)
Employer Resources (207)
FDA (18486)
Job Trends (17459)
News (398360)
Policy (40006)
Tag
2027 BioCapital Elite (1)
2027 BioMidwest Elite (1)
2027 Biotech Bay Standard (2)
2027 Biotech Beach Elite (1)
2027 Genetown Elite (3)
2027 Genetown Standard (1)
2027 Pharm Country Elite (1)
2027 Pharm Country Premier (1)
2027 Pharm Country Standard (4)
Academia (3037)
Academic (2)
Accelerated approval (46)
Adcomms (37)
Allergies (175)
Alliances (56985)
ALS (209)
Alzheimer's disease (1899)
Antibody-drug conjugate (ADC) (433)
Approvals (18730)
Artificial intelligence (755)
Autoimmune disease (257)
Automation (55)
Bankruptcy (407)
Best Places to Work (12634)
BIOSECURE Act (23)
Biosimilars (223)
Biotechnology (486)
Bladder cancer (187)
Brain cancer (75)
Breast cancer (737)
Cancer (5776)
Cardiovascular disease (512)
Career advice (3584)
Career pathing (47)
CAR-T (337)
CDC (72)
Celiac Disease (2)
Cell therapy (929)
Cervical cancer (45)
Clinical research (77977)
Collaboration (2142)
Company closure (7)
Compensation (1338)
Complete response letters (96)
COVID-19 (3018)
CRISPR (111)
C-suite (1088)
Cystic fibrosis (161)
Data (7372)
Decentralized trials (3)
Denatured (82)
Depression (179)
Dermatology (67)
Diabetes (598)
Diagnostics (7426)
Digital health (59)
Diversity (13)
Diversity, equity & inclusion (49)
Drug discovery (378)
Drug pricing (239)
Drug shortages (39)
Duchenne muscular dystrophy (287)
Earnings (101364)
Editorial (72)
Employer branding (25)
Employer resources (174)
Events (136665)
Executive appointments (1121)
FDA (22126)
Fibrodysplasia Ossificans Progressiva (7)
Friedreich's ataxia (14)
Frontotemporal dementia (33)
Funding (1769)
Gene editing (240)
Generative AI (84)
Gene therapy (760)
GLP-1 (1217)
Government (5516)
Grass and pollen (8)
Guidances (404)
Healthcare (21048)
HIV (82)
Huntington's disease (58)
IgA nephropathy (98)
Immunology and inflammation (330)
Immuno-oncology (96)
Indications (164)
Infectious disease (3375)
Inflammatory bowel disease (224)
Inflation Reduction Act (17)
Influenza (141)
Intellectual property (287)
Interviews (817)
IPO (17977)
IRA (61)
Job creations (5205)
Job search strategy (2869)
JPM (73)
Kidney cancer (20)
Labor market (106)
Layoffs (671)
Leadership (46)
Legal (10169)
Liver cancer (106)
Longevity (30)
Lung cancer (767)
Lymphoma (421)
Machine learning (57)
Management (66)
Manufacturing (1048)
MASH (196)
Medical device (15167)
Medtech (15253)
Mergers & acquisitions (23137)
Metabolic disorders (1613)
mRNA (218)
Multiple sclerosis (186)
NASH (24)
Neurodegenerative disease (440)
Neuropsychiatric disorders (117)
Neuroscience (3456)
Neurotech (2)
NextGen: Class of 2026 (7713)
Non-profit (5131)
Now hiring (75)
Obesity (787)
Opinion (359)
Ovarian cancer (202)
Pain (255)
Pancreatic cancer (276)
Parkinson's disease (373)
Partnered (39)
Patents (594)
Patient recruitment (643)
Peanut (65)
People (67482)
Pharmaceutical (138)
Pharmacy benefit managers (36)
Phase 1 (24086)
Phase 2 (33854)
Phase 3 (25477)
Pipeline (7579)
Policy (374)
Postmarket research (3555)
Preclinical (10802)
Press Release (72)
Prostate cancer (295)
Psychedelics (61)
Radiopharmaceuticals (336)
Rare diseases (1129)
Real estate (7448)
Recruiting (81)
Regulatory (29747)
Reports (74)
Research institute (2756)
Resumes & cover letters (653)
Rett syndrome (34)
RNA editing (23)
RSV (96)
Schizophrenia (181)
Series A (294)
Series B (219)
Service/supplier (30)
Sickle cell disease (115)
Special edition (29)
Spinal muscular atrophy (186)
Sponsored (52)
Startups (4350)
State (2)
Stomach cancer (21)
Supply chain (139)
Tariffs (104)
The Weekly (135)
Vaccines (1238)
Venture capital (111)
Weight loss (539)
Women's health (120)
Worklife (23)
Date
Today (143)
Last 7 days (564)
Last 30 days (2733)
Last 365 days (32886)
2026 (9479)
2025 (33227)
2024 (38126)
2023 (42567)
2022 (53929)
2021 (58724)
2020 (57666)
2019 (51337)
2018 (39122)
2017 (37190)
2016 (38330)
2015 (44433)
2014 (39672)
2013 (36268)
2012 (38416)
2011 (38383)
2010 (39616)
Location
Africa (1293)
Alabama (100)
Alaska (7)
Arizona (372)
Arkansas (16)
Asia (51918)
Australia (9122)
California (12936)
Canada (3669)
China (1357)
Colorado (558)
Connecticut (567)
Delaware (392)
Europe (119549)
Florida (1937)
Georgia (424)
Hawaii (4)
Idaho (69)
Illinois (1105)
India (92)
Indiana (609)
Iowa (24)
Japan (520)
Kansas (138)
Kentucky (52)
Louisiana (44)
Maine (87)
Maryland (1595)
Massachusetts (9478)
Michigan (394)
Minnesota (735)
Mississippi (7)
Missouri (156)
Montana (37)
Nebraska (30)
Nevada (144)
New Hampshire (90)
New Jersey (3482)
New Mexico (33)
New York (3432)
North Carolina (1768)
North Dakota (10)
Northern California (6312)
Ohio (402)
Oklahoma (26)
Oregon (54)
Pennsylvania (2589)
Puerto Rico (29)
Rhode Island (53)
South America (1668)
South Carolina (83)
South Dakota (2)
Southern California (5048)
Tennessee (206)
Texas (2087)
United States (46606)
Utah (390)
Vermont (1)
Virginia (330)
Washington D.C. (88)
Washington State (1070)
West Virginia (4)
Wisconsin (144)
Wyoming (2)
There are 877,149 results that match your search.
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Gene editing
FDA bolsters bespoke therapy framework with new draft safety guidelines
The draft guidance supports the agency’s new pathway designed to speed up the development of custom gene therapies.
April 14, 2026
·
2 min read
·
Gabrielle Masson
Cytiva
Cytiva, now with the life sciences business from Pall Corporation, is a global biotechnology leader dedicated to helping customers discover and commercialize the next generation of therapeutics. We bring dedicated technical expertise and a broad portfolio of tools, technologies, and services that enable the development, manufacture, and delivery of transformative medicines to patients. We’re the provider of leading life science brands such as ÄKTA, Amersham, HyClone, MabSelect and Whatman.
Press Releases
Phrontline Biopharma Presents Preclinical Data for TJ106, a Biparatopic HER2 Dual-Payload ADC, at American Association for Cancer Research Annual Meeting 2026
April 14, 2026
·
3 min read
Press Releases
Culture Biosciences Announces Strategic Addition to Its Board of Directors to Accelerate Hardware Commercialization and SaaS Growth
April 14, 2026
·
2 min read
Press Releases
4D Path Announces Collaboration with Daiichi Sankyo to Advance AI-Driven Predictive Biomarkers for an Antibody Drug Conjugate Program
April 14, 2026
·
3 min read
Press Releases
Findings From Long-Term Analysis of the Effects of LYBALVI® (olanzapine and samidorphan) on Negative Symptoms of Schizophrenia Published in The Journal of Clinical Psychiatry
April 14, 2026
·
16 min read
Press Releases
Parabilis Medicines Expands Executive Leadership Team
April 14, 2026
·
5 min read
Press Releases
Merakris Therapeutics and iFyber Collaboration Receives Top SAWC Research Award for MTX-001 Wound Healing Study in Human Skin Model
April 14, 2026
·
5 min read
Press Releases
Neomorph to Highlight Progress in Targeted Protein Degradation Science at the American Association for Cancer Research Annual Meeting
April 14, 2026
·
3 min read
Layoffs
50 employees impacted as Astellas closes Universal Cells’ Seattle office
By closing the Universal Cells Seattle location, Astellas is reportedly consolidating cell therapy, gene therapy and oncology research at its South San Francisco, California, and Westborough, Massachusetts, sites.
April 14, 2026
·
2 min read
·
Angela Gabriel
1 of 87,715
Next
